| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | NBPF | 2.43e-06 | 11 | 47 | 3 | PS51316 | |
| Domain | DUF1220 | 2.43e-06 | 11 | 47 | 3 | PF06758 | |
| Domain | NBPF_dom | 2.43e-06 | 11 | 47 | 3 | IPR010630 | |
| Domain | Mob1_phocein | 1.29e-04 | 7 | 47 | 2 | PF03637 | |
| Domain | MOB_kinase_act_fam | 1.29e-04 | 7 | 47 | 2 | IPR005301 | |
| Domain | - | 1.29e-04 | 7 | 47 | 2 | 1.20.140.30 | |
| Domain | Mob1_phocein | 1.29e-04 | 7 | 47 | 2 | SM01388 | |
| Domain | DUF1220 | 2.21e-04 | 9 | 47 | 2 | SM01148 | |
| Domain | CUB | 6.76e-03 | 49 | 47 | 2 | PF00431 | |
| Domain | CUB | 7.03e-03 | 50 | 47 | 2 | SM00042 | |
| Domain | - | 7.59e-03 | 52 | 47 | 2 | 2.60.120.290 | |
| Domain | CUB | 7.87e-03 | 53 | 47 | 2 | PS01180 | |
| Domain | CUB_dom | 9.06e-03 | 57 | 47 | 2 | IPR000859 | |
| Pubmed | 1.25e-15 | 21 | 52 | 7 | 16079250 | ||
| Pubmed | Evolutionary history and genome organization of DUF1220 protein domains. | 9.27e-10 | 10 | 52 | 4 | 22973535 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 30349003 | ||
| Pubmed | Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice. | 2.19e-06 | 2 | 52 | 2 | 23143302 | |
| Pubmed | S-adenosylhomocysteine Hydrolase Participates in DNA Methylation Inheritance. | 2.19e-06 | 2 | 52 | 2 | 29758262 | |
| Pubmed | Human Mob1 proteins are required for cytokinesis by controlling microtubule stability. | 2.19e-06 | 2 | 52 | 2 | 22454515 | |
| Pubmed | Lineage-specific gene duplication and loss in human and great ape evolution. | 3.57e-06 | 69 | 52 | 4 | 15252450 | |
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 5.68e-06 | 170 | 52 | 5 | 23314748 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 25389112 | ||
| Pubmed | EGFR Regulates the Hippo pathway by promoting the tyrosine phosphorylation of MOB1. | 6.57e-06 | 3 | 52 | 2 | 34725466 | |
| Pubmed | The human tumour suppressor LATS1 is activated by human MOB1 at the membrane. | 6.57e-06 | 3 | 52 | 2 | 16674920 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 26856538 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 30804206 | ||
| Pubmed | PTEN-GSK3β-MOB1 axis controls neurite outgrowth in vitro and in vivo. | 1.31e-05 | 4 | 52 | 2 | 30069702 | |
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 23652010 | ||
| Pubmed | Mechanism of activation of NDR (nuclear Dbf2-related) protein kinase by the hMOB1 protein. | 1.31e-05 | 4 | 52 | 2 | 15197186 | |
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 18579682 | ||
| Pubmed | YAP1 is a potent driver of the onset and progression of oral squamous cell carcinoma. | 2.19e-05 | 5 | 52 | 2 | 32206709 | |
| Pubmed | Oxidative stress-CBP axis modulates MOB1 acetylation and activates the Hippo signaling pathway. | 2.19e-05 | 5 | 52 | 2 | 35349706 | |
| Pubmed | 2.86e-05 | 399 | 52 | 6 | 37536630 | ||
| Pubmed | Phylogenetic conservation of a limb-specific, cis-acting regulator of Sonic hedgehog ( Shh). | 3.28e-05 | 6 | 52 | 2 | 14727139 | |
| Pubmed | 3.28e-05 | 6 | 52 | 2 | 35858357 | ||
| Pubmed | Endogenous YAP1 activation drives immediate onset of cervical carcinoma in situ in mice. | 3.28e-05 | 6 | 52 | 2 | 32716083 | |
| Pubmed | YAP determines the cell fate of injured mouse hepatocytes in vivo. | 3.28e-05 | 6 | 52 | 2 | 28681838 | |
| Pubmed | 4.58e-05 | 7 | 52 | 2 | 11850405 | ||
| Pubmed | MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation. | 4.58e-05 | 7 | 52 | 2 | 18328708 | |
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 19739119 | ||
| Pubmed | Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice. | 6.10e-05 | 8 | 52 | 2 | 26699479 | |
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 20664053 | ||
| Pubmed | 7.84e-05 | 9 | 52 | 2 | 12455637 | ||
| Pubmed | 7.84e-05 | 9 | 52 | 2 | 16960803 | ||
| Pubmed | Progression of vertebrate limb development through SHH-mediated counteraction of GLI3. | 9.79e-05 | 10 | 52 | 2 | 12215652 | |
| Pubmed | Homeostatic control of metabolic and functional fitness of Treg cells by LKB1 signalling. | 9.79e-05 | 10 | 52 | 2 | 28847007 | |
| Pubmed | Function and regulation of Alx4 in limb development: complex genetic interactions with Gli3 and Shh. | 9.79e-05 | 10 | 52 | 2 | 16039644 | |
| Pubmed | 9.79e-05 | 10 | 52 | 2 | 22841643 | ||
| Pubmed | 1.15e-04 | 513 | 52 | 6 | 25798074 | ||
| Pubmed | 1.20e-04 | 11 | 52 | 2 | 19248778 | ||
| Pubmed | 1.20e-04 | 11 | 52 | 2 | 19386268 | ||
| Pubmed | 1.43e-04 | 12 | 52 | 2 | 19211672 | ||
| Pubmed | The molecular basis of Pallister Hall associated polydactyly. | 1.43e-04 | 12 | 52 | 2 | 17588959 | |
| Pubmed | T396I mutation of mouse Sufu reduces the stability and activity of Gli3 repressor. | 1.69e-04 | 13 | 52 | 2 | 25760946 | |
| Pubmed | Ptch2 shares overlapping functions with Ptch1 in Smo regulation and limb development. | 1.69e-04 | 13 | 52 | 2 | 25448692 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 1.84e-04 | 560 | 52 | 6 | 21653829 | |
| Pubmed | Genetic interaction between Gli3 and Ezh2 during limb pattern formation. | 1.97e-04 | 14 | 52 | 2 | 29729398 | |
| Pubmed | 1.97e-04 | 14 | 52 | 2 | 29183995 | ||
| Pubmed | 1.97e-04 | 14 | 52 | 2 | 25581370 | ||
| Pubmed | 1.97e-04 | 14 | 52 | 2 | 23473983 | ||
| Pubmed | 1.97e-04 | 14 | 52 | 2 | 23171847 | ||
| Pubmed | Convergent animal and human evidence suggests a role of PPM1A gene in response to antidepressants. | 2.27e-04 | 15 | 52 | 2 | 20970119 | |
| Pubmed | Twist1 activity thresholds define multiple functions in limb development. | 2.27e-04 | 15 | 52 | 2 | 20732316 | |
| Pubmed | Transcriptional dynamics of delaminating neuroblasts in the mouse otic vesicle. | 2.27e-04 | 15 | 52 | 2 | 37227818 | |
| Pubmed | 2.60e-04 | 16 | 52 | 2 | 21795281 | ||
| Pubmed | 2.60e-04 | 16 | 52 | 2 | 12193642 | ||
| Pubmed | 2.60e-04 | 16 | 52 | 2 | 24726283 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 2.82e-04 | 861 | 52 | 7 | 36931259 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 2.89e-04 | 212 | 52 | 4 | 33853758 | |
| Pubmed | 2.94e-04 | 17 | 52 | 2 | 24726282 | ||
| Pubmed | The Fused toes (Ft) mouse mutation causes anteroposterior and dorsoventral polydactyly. | 3.30e-04 | 18 | 52 | 2 | 12413903 | |
| Pubmed | 3.30e-04 | 18 | 52 | 2 | 24424161 | ||
| Pubmed | 3.30e-04 | 18 | 52 | 2 | 27352137 | ||
| Pubmed | 3.30e-04 | 18 | 52 | 2 | 22178153 | ||
| Pubmed | 3.30e-04 | 18 | 52 | 2 | 28346423 | ||
| Pubmed | 3.30e-04 | 18 | 52 | 2 | 20386744 | ||
| Pubmed | Hox5 interacts with Plzf to restrict Shh expression in the developing forelimb. | 4.09e-04 | 20 | 52 | 2 | 24218595 | |
| Pubmed | FGF-regulated Etv genes are essential for repressing Shh expression in mouse limb buds. | 4.52e-04 | 21 | 52 | 2 | 19386269 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 4.55e-04 | 430 | 52 | 5 | 35044719 | |
| Pubmed | 4.65e-04 | 432 | 52 | 5 | 7671812 | ||
| Pubmed | 4.88e-04 | 102 | 52 | 3 | 10231032 | ||
| Pubmed | Mesodermal Tbx1 is required for patterning the proximal mandible in mice. | 4.97e-04 | 22 | 52 | 2 | 20501333 | |
| Pubmed | Hedgehog signaling patterns the oral-aboral axis of the mandibular arch. | 4.97e-04 | 22 | 52 | 2 | 30638444 | |
| Pubmed | 5.37e-04 | 446 | 52 | 5 | 24255178 | ||
| Pubmed | 5.44e-04 | 23 | 52 | 2 | 16672333 | ||
| Pubmed | 5.44e-04 | 23 | 52 | 2 | 38828908 | ||
| Pubmed | 6.43e-04 | 25 | 52 | 2 | 22438573 | ||
| Pubmed | 6.43e-04 | 25 | 52 | 2 | 37493331 | ||
| Pubmed | A chemical tool for blue light-inducible proximity photo-crosslinking in live cells. | 6.43e-04 | 25 | 52 | 2 | 35211260 | |
| Pubmed | 6.96e-04 | 26 | 52 | 2 | 24415953 | ||
| Pubmed | Interaction proteome of human Hippo signaling: modular control of the co-activator YAP1. | 7.18e-04 | 270 | 52 | 4 | 24366813 | |
| Pubmed | AMPK Interactome Reveals New Function in Non-homologous End Joining DNA Repair. | 8.02e-04 | 121 | 52 | 3 | 31900314 | |
| Pubmed | Nrg1 Regulates Cardiomyocyte Migration and Cell Cycle in Ventricular Development. | 8.08e-04 | 28 | 52 | 2 | 37846569 | |
| Pubmed | 8.67e-04 | 29 | 52 | 2 | 26959361 | ||
| Pubmed | Loss of Neogenin alters branchial arch development and leads to craniofacial skeletal defects. | 9.29e-04 | 30 | 52 | 2 | 38404688 | |
| Pubmed | 9.65e-04 | 129 | 52 | 3 | 23022380 | ||
| Pubmed | 1.49e-03 | 38 | 52 | 2 | 33913477 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 3.69e-07 | 404 | 52 | 7 | chr1q21 | |
| Cytoband | 1q21.1 | 4.94e-05 | 62 | 52 | 3 | 1q21.1 | |
| Cytoband | 22q12.1 | 6.11e-04 | 32 | 52 | 2 | 22q12.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q13 | 2.07e-03 | 59 | 52 | 2 | chr2q13 | |
| Cytoband | 1q21.2 | 2.97e-03 | 71 | 52 | 2 | 1q21.2 | |
| GeneFamily | Neuroblastoma breakpoint family | 5.14e-17 | 23 | 36 | 8 | 662 | |
| GeneFamily | MOB kinase activators|STRIPAK complex | 8.04e-05 | 7 | 36 | 2 | 647 | |
| ToppCell | COVID-19_Convalescent|World / Disease condition and Cell class | 2.22e-06 | 181 | 52 | 5 | a62115a8da486fc61225901c72b1ec70bcaf4c36 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.20e-06 | 195 | 52 | 5 | e87b11e3242fdbed2e7f383e6876ec375af32bd4 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.62e-06 | 200 | 52 | 5 | f75d95376a340d467c4392b872b2a2dbdd184556 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1--L3-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.62e-06 | 200 | 52 | 5 | 47791c93d03ee17c1ce17e27f075be4fc6f2590e | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.62e-06 | 200 | 52 | 5 | fae26560ba3b0b638b6bcf92f05330824b31d21b | |
| ToppCell | Control-B_intermediate-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.42e-05 | 144 | 52 | 4 | 984470ff6ddce4c743e2db78fa98dae055aaa273 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell-Schwann_Cell_/_Neural-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-05 | 154 | 52 | 4 | 30cb4bb297fa815adb829f3b5cafca56fcbcb810 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell-Schwann_Cell_/_Neural|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-05 | 154 | 52 | 4 | ade094e2947761a0a34daa8fcff3e9ea8437e4a5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-05 | 154 | 52 | 4 | 42bd8f88fd075a2d4edde394785decad88a2660a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-05 | 154 | 52 | 4 | 6425d9861148586466febd6eceae1b1f9b9a14c1 | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.31e-05 | 167 | 52 | 4 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.95e-05 | 173 | 52 | 4 | 8ac2e9d39c0f76e674f8bd59d1da246bab4867c8 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.77e-05 | 180 | 52 | 4 | 7c7c4d64ff99d0710a7d19d8bc29fc9217394db1 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.77e-05 | 180 | 52 | 4 | b234668bf181522807470e396792e1b54890b719 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.03e-05 | 182 | 52 | 4 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-05 | 187 | 52 | 4 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.69e-05 | 187 | 52 | 4 | d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.83e-05 | 188 | 52 | 4 | ee572246e0c2f41bdbc29a03edc67b831af95c09 | |
| ToppCell | COPD-Myeloid-cMonocyte|COPD / Disease state, Lineage and Cell class | 6.98e-05 | 189 | 52 | 4 | d29f3a0bd23e6eb46389e6eb7ef21851c7b57545 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 191 | 52 | 4 | fd345837bfc40d85256b9a7e4fd3343bcbfe0ae5 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 7.56e-05 | 193 | 52 | 4 | ca7c0a4ceb05bced90f6cdc53d278e547fb241e9 | |
| ToppCell | COVID-19_Convalescent-PLT_4|COVID-19_Convalescent / Disease Group and Platelet Clusters | 7.72e-05 | 194 | 52 | 4 | ce1fad4e76a87f0c35e430ed1f2262395df882fd | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.72e-05 | 194 | 52 | 4 | 46070fbb0ee0eb9e1801c43b73a15707471056dc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.72e-05 | 194 | 52 | 4 | abacb6a8d7a9003f2f6c2be0305507f1c1c50347 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.68e-05 | 200 | 52 | 4 | 16f468217427921fa18c6d078ffa990eb019b257 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.68e-05 | 200 | 52 | 4 | d6fcbf4f4bc1b89a9929d7b114c6b907b6979900 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.68e-05 | 200 | 52 | 4 | f861509b54185d89931db64da1b9d81986cc7938 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.68e-05 | 200 | 52 | 4 | c74bc12e13d002dedaaf75a2244ec111e47524e1 | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-B-B_naive|COVID-19_Convalescent / Disease, condition lineage and cell class | 8.68e-05 | 200 | 52 | 4 | 5c1b51b9571681d8b792d1443d9f8926dcd55b29 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.68e-05 | 200 | 52 | 4 | 0442894c39eec69850c090957a5dc7bcecd21e04 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.68e-05 | 200 | 52 | 4 | ead9eb579bb25fde05fc15602e3d05ab6617f7ac | |
| ToppCell | Macroglial-Astrocytes-SLC14A1-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.68e-05 | 200 | 52 | 4 | 01819446deeab9054f5cfe889d53bb49d137dbc0 | |
| Drug | Pesticides | 3.69e-08 | 150 | 50 | 7 | ctd:D010575 | |
| Disease | alcohol consumption measurement, waist-hip ratio | 1.36e-05 | 4 | 45 | 2 | EFO_0004343, EFO_0007878 | |
| Disease | synophrys measurement | 1.55e-04 | 68 | 45 | 3 | EFO_0007906 | |
| Disease | uterine fibroid | 2.41e-04 | 199 | 45 | 4 | EFO_0000731 | |
| Disease | otosclerosis | 2.60e-04 | 81 | 45 | 3 | EFO_0004213 | |
| Disease | lymphocyte:monocyte ratio | 9.67e-04 | 288 | 45 | 4 | EFO_0600088 | |
| Disease | Arthritis, Experimental | 1.71e-03 | 40 | 45 | 2 | C0993582 | |
| Disease | Arthritis, Adjuvant-Induced | 1.71e-03 | 40 | 45 | 2 | C0003865 | |
| Disease | Arthritis, Collagen-Induced | 1.71e-03 | 40 | 45 | 2 | C0971858 | |
| Disease | virologic response measurement, response to abacavir | 1.88e-03 | 42 | 45 | 2 | EFO_0006905, EFO_0006906 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 2.20e-03 | 169 | 45 | 3 | DOID:3908 (is_marker_for) | |
| Disease | response to hydrochlorothiazide, triglyceride measurement | 2.35e-03 | 47 | 45 | 2 | EFO_0004530, EFO_0005202 | |
| Disease | hair colour measurement | 2.38e-03 | 615 | 45 | 5 | EFO_0007822 | |
| Disease | cholestasis (biomarker_via_orthology) | 2.56e-03 | 49 | 45 | 2 | DOID:13580 (biomarker_via_orthology) | |
| Disease | glucose-dependent insulinotropic peptide measurement | 2.98e-03 | 53 | 45 | 2 | EFO_0008464 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ESPAAAMDAYYSPVS | 11 | Q9H161 | |
| NPEDGMADYSDPSYV | 451 | Q99459 | |
| TSFAEYILMDPSPEY | 481 | P26358 | |
| YFSFDTDRSPAPMSC | 96 | O43521 | |
| DPLDAGVDYSGYSPM | 781 | Q8NB46 | |
| PGPEMEYCTDRESYS | 1281 | Q9H1A4 | |
| YNCPGQYTFSMPSDS | 66 | Q07108 | |
| DPTICGYNFDPKTYM | 551 | Q9P2D6 | |
| MSSVVYSPDFPDTYA | 221 | Q96MU8 | |
| EYTYRCLMSPENSDP | 566 | Q02153 | |
| EMADSPEFTSIPACY | 401 | Q9UIX4 | |
| EESCPVMSAGPKYEY | 81 | Q7L9L4 | |
| PDYSMALSYSPEYAS | 56 | P61296 | |
| YGESSAPPEIEEYCM | 296 | P34913 | |
| PMDEHSCPLEFSSYG | 196 | Q8N1C3 | |
| RQADSCPYGTMYLSP | 126 | Q6UUV9 | |
| EEVLYYTSGCAPSMP | 456 | Q9Y2H6 | |
| TPAEMLDFFNDCGYP | 276 | Q9H222 | |
| PAFESYESMELACPA | 16 | Q9Y2U9 | |
| GAPGTLMTAPEYYEF | 321 | Q5D0E6 | |
| SYKCSMEQGLYPTFP | 416 | Q5D0E6 | |
| SFITYDGSMTIPPCY | 231 | Q9NS85 | |
| YLGMSCDGPFKPDHY | 416 | P23526 | |
| QDPPLSSDGMYEYGS | 256 | Q9UMX9 | |
| YAMTYAPASAFCSSP | 191 | O43186 | |
| SYTDVMCNPFYNPGD | 106 | Q9UL33 | |
| YLPGESLTFMCYEGF | 891 | Q9BYH1 | |
| FGEMGLDYSYKCTTP | 591 | Q93075 | |
| LCYYLSPPESMGAIF | 341 | Q9H9S3 | |
| QDSLDGCYSTPSMYF | 1046 | P0DPF3 | |
| GCYSTPSMYFELPDS | 1051 | P0DPF3 | |
| CYSTPSMYFELPDSF | 3736 | Q6P3W6 | |
| DRCYSTPSMYFELPD | 1396 | Q5TAG4 | |
| ICYSTPSMYFELPDS | 861 | Q5TI25 | |
| CYSTPSMYFEQPDSF | 611 | Q8N660 | |
| LDGCYSTPSMYFELP | 3781 | A0A087WUL8 | |
| DGCYSTPSMYFELPD | 5146 | P0DPF2 | |
| DICYSTPSMYFELPD | 841 | B4DH59 | |
| EASCPVMSAGPRYEY | 81 | Q9H8S9 | |
| YYEPFGPDECTMYLS | 271 | Q9BVH7 | |
| FPSSMPECLSYYEDR | 641 | O94993 | |
| YPDGTEQYFGSPSDM | 651 | Q86VW0 | |
| YLFPEDPSYSSTMID | 286 | Q13131 | |
| PLEEFYSFGESMCEY | 261 | Q6P3X8 | |
| EPDQYSLGSYAPMSE | 1196 | Q9Y4G8 | |
| LMDYCYTTPSGNPND | 231 | Q8TCW7 | |
| YGDTVMYGLESSPCS | 116 | Q7Z2H8 | |
| FYMSSPGPSEYCPSE | 736 | Q08AE8 | |
| AEMPADSGYPAYLGA | 366 | P38606 | |
| LCSEYYMKEPGEADP | 736 | Q9BTW9 | |
| EMYLPFPGRSASYED | 2146 | Q5VWN6 | |
| GYFAMSEDELACSPY | 6 | Q96IP4 | |
| EYDGEHDCMFLDPPY | 366 | O43164 | |
| PPYEFSCSSAEEMGA | 246 | O15049 |